Reimbursement and access models for digital therapeutics

Friday 14th May
16:00 CET 15:00 BST 10:00 EDT



Healthcare providers, insurance, workplace and direct-to-consumer

Unlike traditional FMCG there are lots of different reimbursement options for direct-to-consumer digital therapeutics in mental health, women’s health, nutrition and lifestyle improvement.

This session looks at assorted reimbursement pathways including via healthcare providers, insurance, workplace and direct-to-consumer, including regional differences and opportunities, and presents entrepreneurs with a variety of challenges and benefits to consider when launching their platforms.

Sara Patti, Head of Healthcare Innovation, Allianz Partners

Sara Patti

Head of Healthcare Innovation
Allianz Partners
Guido Hegener, Managing Partner, Digital Health Ventures

Guido Hegener

Managing Partner
Digital Health Ventures
Amir Zur, Head of Product and Quality, Digital Health, Teva Pharmaceuticals

Amir Zur

Head of Product and Quality, Digital Health
Teva Pharmaceuticals
Ivan Ostojic, Partner, DTx, McKinsey & Company

Ivan Ostojic

Partner, DTx
McKinsey & Company

Register here


The Healthspan Show

This session is part of The Healthspan Show taking place 10-14 May 2021

You can see the full agenda, speakers and partnering opportunities by downloading the brochure.